Prenetics Global Limited (PRE)
NASDAQ: PRE · Real-Time Price · USD
17.80
+2.73 (18.12%)
At close: Mar 6, 2026, 4:00 PM EST
17.80
0.00 (0.00%)
After-hours: Mar 6, 2026, 4:00 PM EST

Company Description

Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally.

It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand.

The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide comprehensive insights into health, wellness, and genetic predispositions.

Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Prenetics Global Limited
Prenetics Global logo
Country Hong Kong
Founded 2014
Industry Diagnostics & Research
Sector Healthcare
Employees 285
CEO Sheng Wu Yeung

Contact Details

Address:
Unit 703-706, K11 Atelier King’s Road, 728 King’s Road
Quarry Bay
Hong Kong
Phone 852 2210 9588
Website prenetics.com

Stock Details

Ticker Symbol PRE
Exchange NASDAQ
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001876431
CUSIP Number G72245106
ISIN Number KYG722451229
SIC Code 3826

Key Executives

Name Position
Samantha Kwok Chief of Staff to Group Chief Executive Officer and Vice President of People & Operations
Sheng Wu Yeung Co-Founder, Chairperson and Chief Executive Officer
Dr. Chi Hung Tzang Ph.D. Co-Founder and Chief Scientific Officer
Hoi Chun Lo Chief Financial Officer
Dr. Senthil Kumar Sundaram M.D. Chief Clinical Officer
Joel Neoh Chief Consumer Officer
David Eric Vanderveen Director and President of Americas
Dr. James DiNicolantonio Chief Nutrition Officer, Member of Scientific and Medical Advisory Board

Latest SEC Filings

Date Type Title
Mar 6, 2026 6-K Report of foreign issuer
Mar 3, 2026 6-K Report of foreign issuer
Feb 18, 2026 6-K Report of foreign issuer
Feb 17, 2026 6-K Report of foreign issuer
Feb 17, 2026 6-K Report of foreign issuer
Jan 6, 2026 6-K Report of foreign issuer
Jan 5, 2026 6-K Report of foreign issuer
Dec 30, 2025 6-K Report of foreign issuer
Dec 23, 2025 6-K Report of foreign issuer
Dec 11, 2025 6-K Report of foreign issuer